8,458 Shares in The Clorox Company $CLX Bought by Soltis Investment Advisors LLC

Soltis Investment Advisors LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, HoldingsChannel reports. The firm purchased 8,458 shares of the company’s stock, valued at approximately $685,000.

Several other hedge funds have also recently added to or reduced their stakes in CLX. Ancora Advisors LLC bought a new stake in shares of Clorox in the 2nd quarter valued at $28,000. Avalon Trust Co acquired a new stake in shares of Clorox during the second quarter worth $29,000. Markowski Investments acquired a new stake in shares of Clorox during the second quarter worth $30,000. Root Financial Partners LLC increased its position in shares of Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares during the period. Finally, Pension & Wealth Management Advisors Inc. bought a new position in Clorox during the third quarter worth $26,000. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $88.01 on Friday. The stock has a market capitalization of $10.64 billion, a price-to-earnings ratio of 18.26, a PEG ratio of 2.94 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The stock’s 50 day moving average price is $88.61 and its two-hundred day moving average price is $100.01. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping the consensus estimate of $1.64 by $0.02. The company had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company’s quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities analysts predict that The Clorox Company will post 5.66 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, October 28th. This represents a $5.00 annualized dividend and a yield of 5.7%. Clorox’s dividend payout ratio is currently 103.73%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CLX shares. JPMorgan Chase & Co. dropped their target price on shares of Clorox from $95.00 to $83.00 and set an “underweight” rating on the stock in a report on Monday, October 19th. Wall Street Zen cut shares of Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, October 3rd. Evercore set a $99.00 price target on Clorox in a report on Tuesday, August 4th. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research report on Thursday. Finally, Wells Fargo & Company lowered their price objective on Clorox from $90.00 to $85.00 and set an “equal weight” rating for the company in a research report on Monday, October 5th. Eleven research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $93.57.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
• Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
• Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
• Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

About Clorox

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.